Reporter Sept 16 2022

Bariatric surgery patient Veronica Llamas-Barajas recently received a heart transplant.
September 15, 2022

Patient’s care journey included LVAD, bariatric surgery, transplant

When Veronica Llamas-Barajas received a heart transplant at Vanderbilt University Medical Center in April, it was the culmination of a seven-year journey.

By Matt Batcheldor
The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.
September 15, 2022

Study suggests new mechanism for lipid transporter

A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.

By Leigh MacMillan
Former patient Herbert Christopher poses for a photo with Elizabeth Perkins, MD, the first Christopher fellow of Otolaryngology.
September 15, 2022

Gifts bolster otolaryngology, Alzheimer’s disease programs

Herbert Christopher, a grateful Otolaryngology–Head and Neck Surgery patient who received cochlear hearing implants from David Haynes, MD, has funded the training of otolaryngology fellows and leaders in Alzheimer’s disease care through several outright endowed gifts and additional gift planning with his estate.

By Emily Stembridge
September 14, 2022

Hodges, Nakagawa receive Cohen Innovation funds

Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds

By VUMC News and Communications
September 14, 2022

Complementary research, resources, policies improve outcomes for those with substance use disorders: panel

A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.

By Jill Clendening
September 13, 2022

Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

By Tom Wilemon